Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 11/16/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Kehinde Adekola MD, MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN | None | None | None | ✔ |
| Larry Anderson, Jr. MD, PhD | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Celgene Corporation GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Celgene Corporation GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
None | ✔ |
| Muhamed Baljevic MD | Amgen Inc. Bristol Myers Squibb Exelixis Inc. Karyopharm Therapeutics |
None | AlphaSights Aptitude Health Case Series on Hematologic Malignancies Atheneum Bristol Myers Squibb Cardinal Health Specialty Solutions Oncology Coleman Research GLG individual consultations Guidepoint Global Karyopharm Therapeutics MediCom Worldwide Inc. MM MRD Roundtable clonoSEQ NCCN 2020 Virtual Congress: Hematologic Malignancies Putnam Associates Trinity Partners |
None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Natalie Callander MD | None | None | None | None | ✔ |
| Erica Campagnaro MD | None | None | None | None | ✔ |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | ✔ |
| Jason Chandler MD | None | AbbVie, Inc. George Clinical Janssen Pharmaceutica Products, LP |
None | None | - |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Karyopharm Therapeutics Oncopeptides Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Yvonne Efebera MD, MPH | None | None | Akcea pharmaceutical Janssen Pharmaceutica Products, LP Takeda Pharmaceuticals North America, Inc. |
None | ✔ |
| Colleen Erb MSN, AOCNP, CRNP | None | None | None | None | - |
| Matthew Faiman MD, MBA, FACP | None | None | None | None | - |
| Alfred Garfall MD | Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
GSK Janssen Pharmaceutica Products, LP Surface Oncology |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | ✔ |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jens Hillengass MD, PhD | None | Adaptive Bristol Myers Squibb GSK Myeloma 360 |
Curio Science Rapid Payer Response Research to Practice |
None | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | - |
| Leona Holmberg MD, PhD | Bristol Myers Squibb Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | ✔ |
| Myo Htut MD | Celgene Corporation | None | None | None | ✔ |
| Carol Ann Huff MD | Glenmark / Ichnos GSK Karyopharm Therapeutics sanofi-aventis U.S. |
GSK sanofi-aventis U.S. |
None | None | - |
| Malin Hultcrantz MD, PhD | Amgen Inc. Daiichi- Sankyo Co. GSK |
None | None | None | ✔ |
| Yubin Kang MD | Apogee Biotech and RedHill Pharmaceutical Co | None | sanofi-aventis U.S. | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Jennifer Keller MS | None | None | None | None | - |
| Rashmi Kumar PhD | None | None | None | None | - |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol Myers Squibb Carsgen Celgene Corporation GSK MedImmune Inc. Oncogene Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. BeiGene Celgene Corporation Cellectar Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Sarah Larson MD | AbbVie, Inc. Bristol Myers Squibb Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. |
None | None | None | ✔ |
| Michaela Liedtke MD | Agios, Inc. Allogene Caelum Celator Pharmaceuticals Celgene Corporation Genentech, Inc. Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Caelum Celgene Corporation GSK Tanabe |
Amgen Inc. Pfizer Inc. |
None | - |
| Daniel Lui PharmD, BCPPS | None | None | Brand Institute Inc MedPanel MNOW (Sermo) Reckner |
None | - |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GSK | None | None | - |
| Jim Omel MD | None | None | None | none | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Douglas Sborov MD, MSc | Amgen Inc. Bristol Myers Squibb Celgene Corporation GSK Janssen Pharmaceutica Products, LP |
GSK Janssen Pharmaceutica Products, LP SkylineDX |
None | None | ✔ |
| Kenneth Shain MD, PhD | AbbVie, Inc. Karyopharm Therapeutics |
Bristol Myers Squibb GSK |
Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | ✔ |
| Keith Stockerl-Goldstein MD | Cellerant Therapeutics, Inc. | None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | ✔ |
| Donna Weber MD | None | None | None | None | - |